Hepatitis | Guidance and guideline topic | NICE

6 new

and

0 updated

products since January 2017.

NICE Pathways - mapping our guidance

Technology appraisal guidance

Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B (TA96) February 2006
Boceprevir for the treatment of genotype 1 chronic hepatitis C (TA253) April 2012
Daclatasvir for treating chronic hepatitis C (TA364) November 2015
Elbasvir–grazoprevir for treating chronic hepatitis C (TA413) October 2016
Entecavir for the treatment of chronic hepatitis B (TA153) August 2008
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C (TA75) January 2004
Ledipasvir–sofosbuvir for treating chronic hepatitis C (TA363) November 2015
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C (TA365) November 2015
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C (TA200) September 2010
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C (TA106) August 2006
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people (TA300) November 2013
Simeprevir in combination with peginterferon alfa and ribavirin for treating genotypes 1 and 4 chronic hepatitis C (TA331) February 2015
Simeprevir in combination with sofosbuvir for treating genotype 1 or 4 chronic hepatitis C (terminated appraisal) (TA361) October 2015
Sofosbuvir for treating chronic hepatitis C (TA330) February 2015
Sofosbuvir–velpatasvir for treating chronic hepatitis C (TA430) January 2017
Telaprevir for the treatment of genotype 1 chronic hepatitis C (TA252) April 2012
Telbivudine for the treatment of chronic hepatitis B (TA154) August 2008
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal) (TA435) March 2017
Tenofovir disoproxil for the treatment of chronic hepatitis B (TA173) July 2009

Quality standards

Hepatitis B (QS65) July 2014

NICE Guidelines

Hepatitis B (chronic): diagnosis and management (CG165) June 2013
Hepatitis B and C testing: people at risk of infection (PH43) December 2012

Interventional procedures guidance

Stent insertion for bleeding oesophageal varices (IPG392) April 2011

NICE Medtech innovation briefings

The OraQuick HCV point‑of‑care test for rapid detection of hepatitis C virus antibodies (MIB24) March 2015

Medical technologies guidance

Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27) September 2015

In development

Glecaprevir with pibrentasvir for treating chronic hepatitis C [ID1085] (GID-TA10169) March 2018 Technology appraisal guidance
Hepatitis C (GID-CGWAVE0666) TBC NICE guidelines
Hepatitis C (genotype 1, chronic) - faldaprevir [ID670] (GID-TAG456) TBC Technology appraisal guidance
Sofosbuvir-velpatasvir-voxilaprevir for treating chronic hepatitis C [ID1055] (GID-TA10175) May 2018 Technology appraisal guidance